TaspoglutidePharmaceutical InformationUpdated on Jun 11, 2019 View more like this | Visit SHIRLEY, NY | Contact Cathy Miller |

Taspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche.